Task: Answer the multiple-choice question.
Question: Which drug exhibits a -3.813% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC1(C(=O)N2CCN(C(=O)c3ccco3)CC2)CC1(Br)Br
b OCCC1CN(Cc2cccc3nccnc23)CCN1Cc1ccc(F)cc1
c CCOc1ccc(S(=O)(=O)NCc2cccnc2)cc1C
Answer: a. CC1(C(=O)N2CCN(C(=O)c3ccco3)CC2)CC1(Br)Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C(=O)N2CCN(C(=O)c3ccco3)CC2)CC1(Br)Br
CC1(C(=O)N2CCN(C(=O)c3ccco3)CC2)CC1(Br)Br
[4-(2,2-dibromo-1-methylcyclopropanecarbonyl)piperazin-1-yl]-(furan-2-yl)methanone